{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:45:38Z","timestamp":1772012738149,"version":"3.50.1"},"reference-count":301,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3609,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p>The elderly take more antiepileptic drugs (AEDs) than all other adults. This extensive use directly correlates with an increased prevalence of epilepsy in a growing population of older people, as well as other neuropsychiatric conditions such as neuropathic pain and behavioral disorders associated with dementia and for which AEDs are administered. The agents account for nearly 10% of all adverse drug reactions in the elderly and are the fourth leading cause of adverse drug reactions in nursing home residents. Numerous factors associated with advanced age contribute to the high frequency of untoward drug effects in this population; however, strategies are available to ensure optimal outcomes.<\/jats:p>","DOI":"10.1592\/phco.22.5.329.33192","type":"journal-article","created":{"date-parts":[[2004,5,21]],"date-time":"2004-05-21T09:33:50Z","timestamp":1085132030000},"page":"329-364","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Strategies for Optimizing Antiepileptic Drug Therapy in Elderly People"],"prefix":"10.1002","volume":"22","author":[{"given":"Thomas E.","family":"Lackner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.3.7.589"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01294.x"},{"key":"e_1_2_1_4_2","first-page":"7","volume-title":"Seizures and epilepsy in elderly patients","author":"Hauser W.A.","year":"1997"},{"key":"e_1_2_1_5_2","first-page":"70","volume-title":"Proceedings of the drug information association workshop. Geriatric drug use: clinical and social perspectives","author":"Moore S.R.","year":"1985"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1993.tb06483.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241905"},{"key":"e_1_2_1_8_2","first-page":"231","volume-title":"Antiepileptic drugs","author":"Willmore J.L.","year":"1995"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1964.00460240074010"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb06222.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb06654.x"},{"key":"e_1_2_1_12_2","first-page":"335","article-title":"Use of antiepileptic drugs in elderly patient populations","volume":"102","author":"Oles K.S.","year":"1987","journal-title":"Public Health Rep"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(99)00039-X"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90581-2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(95)00085-2"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb05201.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01357.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.3.739"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.3.746"},{"key":"e_1_2_1_20_2","first-page":"63","volume-title":"Seizures and epilepsy in elderly patients","author":"Loisseau P.","year":"1997"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.9.1407"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818020-00004"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199507010-00005"},{"key":"e_1_2_1_24_2","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge B.K.","year":"1999","journal-title":"Neurology"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.20.2200"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530020053014"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)30112-9"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/18.1.17"},{"key":"e_1_2_1_29_2","first-page":"123","volume-title":"Seizures and epilepsy in elderly patients","author":"Tinuper P.","year":"1997"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915010-00002"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91535-8"},{"key":"e_1_2_1_32_2","first-page":"227","volume-title":"The treatment of epilepsy","author":"Tallis R.","year":"1996"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.10.915"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.4.1029"},{"key":"e_1_2_1_35_2","first-page":"179","volume-title":"Seizures and epilepsy in elderly patients","author":"Dodrill C.B.","year":"1997"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1983.tb04647.x"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.2000.0465"},{"key":"e_1_2_1_38_2","first-page":"79","volume-title":"Quality of life and quality of care in epilepsy: update 1993","author":"Tallis R.","year":"1993"},{"key":"e_1_2_1_39_2","first-page":"52","volume-title":"Epilepsy and the older","author":"Fenwick P.","year":"1988"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00166.x"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb01794.x"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1986.tb03534.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.68"},{"issue":"8","key":"e_1_2_1_44_2","first-page":"91","article-title":"Effect of age on epilepsy and its treatment: results from the VA cooperative study [abstr]","volume":"35","author":"Ramsay R.E.","year":"1994","journal-title":"Epilepsia"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.1.44"},{"key":"e_1_2_1_46_2","volume-title":"Drug topics red book","author":"Finkel A.S.","year":"2000"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232107"},{"key":"e_1_2_1_48_2","first-page":"141","volume-title":"Epilepsy: current approaches to diagnosis and treatment","author":"Troupin A.S.","year":"1990"},{"issue":"4","key":"e_1_2_1_49_2","first-page":"547","article-title":"Evidence\u2010based medicine and antiepileptic drugs","volume":"40","author":"Privitera M.D.","year":"1999","journal-title":"Epilepsia"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605050-00005"},{"key":"e_1_2_1_51_2","volume-title":"Felbatol (felbamate) package insert","author":"Wallace Laboratories.","year":"1999"},{"key":"e_1_2_1_52_2","volume-title":"Tegretol (carbamazepine) package insert","author":"Novartis Pharmaceuticals.","year":"2000"},{"key":"e_1_2_1_53_2","volume-title":"Zonegran (zonisamide) package insert","author":"Elan Pharmaceuticals.","year":"2000"},{"key":"e_1_2_1_54_2","volume-title":"Cerebyx (fosphenytoin sodium injection) package insert","author":"Parke\u2010Davis","year":"1999"},{"key":"e_1_2_1_55_2","volume-title":"Dilantin (extended\u2010release phenytoin sodium capsules) package insert","author":"Parke\u2010Davis","year":"1999"},{"key":"e_1_2_1_56_2","volume-title":"Phenytoin sodium injection package insert","author":"Elkins\u2010Sinn","year":"1998"},{"key":"e_1_2_1_57_2","volume-title":"Trileptal (oxcarbazepine) package insert","author":"Novartis Pharmaceuticals.","year":"2000"},{"key":"e_1_2_1_58_2","volume-title":"Donnatal (phenobarbital sodium) package insert","author":"Robins A. H.","year":"1996"},{"key":"e_1_2_1_59_2","volume-title":"Neurontin (gabapentin) package insert","author":"Parke\u2010Davis.","year":"2000"},{"key":"e_1_2_1_60_2","volume-title":"Keppra (levetiracetam) package insert","author":"UCB Pharma.","year":"2000"},{"key":"e_1_2_1_61_2","volume-title":"Gabitril (tiagabine hydrochloride) package insert","author":"Abbott Laboratories.","year":"1999"},{"key":"e_1_2_1_62_2","volume-title":"Topamax (topiramate) package insert","author":"Ortho\u2010McNeil Pharmaceuticals.","year":"2001"},{"key":"e_1_2_1_63_2","volume-title":"Mysoline (primidone) package insert","author":"Athena Neurosciences.","year":"1998"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)47428-3"},{"key":"e_1_2_1_65_2","volume-title":"Klonopin (clonazepam) package insert","author":"Roche Pharma.","year":"1997"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.5.1467-a"},{"key":"e_1_2_1_67_2","volume-title":"Lamictal (lamotrigine) package insert","author":"Glaxo Wellcome.","year":"2001"},{"key":"e_1_2_1_68_2","volume-title":"Depakote (divalproex sodium) package insert","author":"Abbott Laboratories.","year":"2000"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200023010-00003"},{"key":"e_1_2_1_70_2","volume-title":"Drug interactions: a clinical perspective and analysis of current developments","author":"Hansten P.D.","year":"2001"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507183130303"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(95)00016-4"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb00484.x"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.45.12.1119"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6974(05)80094-5"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.49"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01251.x"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb04598.x"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.3.1588"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0690(18)30534-2"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.5.2592"},{"key":"e_1_2_1_82_2","first-page":"1175","article-title":"Randomized study of antiepileptic drug withdrawal in patients in remission","volume":"337","author":"Medical Research Council Antiepileptic Drug Withdrawal Study Group.","year":"1991","journal-title":"Lancet"},{"key":"e_1_2_1_83_2","first-page":"54","volume-title":"Contemporary diagnosis and management of the patient with epilepsy","author":"Leppik I.E.","year":"1998"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804143181502"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.2.600"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb05112.x"},{"key":"e_1_2_1_87_2","unstructured":"Anonymous.Consensus statement of an expert panel convened by Athena Laboratories in Houston TX October 2 1995."},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806253382602"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb02327.x"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05819.x"},{"key":"e_1_2_1_91_2","volume-title":"Diazepam oral solution and Intensol. Data on file","author":"Roxane Laboratories.","year":"1994"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600710227"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1989.tb03246.x"},{"key":"e_1_2_1_94_2","volume-title":"Diastat (diazepam rectal delivery system) package insert","author":"Elan Pharmaceuticals.","year":"1999"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(99)00002-9"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1996.tb02996.x"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199512040-00003"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804023381407"},{"key":"e_1_2_1_99_2","first-page":"1","article-title":"Status epilepticus: treatment in 2001. New approaches, new medicines","volume":"10","author":"Leppik I.E.","year":"2001","journal-title":"MINCEP Epilepsy Reports"},{"issue":"7","key":"e_1_2_1_100_2","first-page":"243","article-title":"Results of a controlled trial of benzodiazepines for the treatment of status epilepticus in the prehospital setting [abstr]","volume":"40","author":"Lowenstein D.H.","year":"1999","journal-title":"Epilepsia"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809173391202"},{"issue":"7","key":"e_1_2_1_102_2","first-page":"243","article-title":"Treatment of status epilepticus if first drug fails [abstr]","volume":"40","author":"Treiman D.M.","year":"1999","journal-title":"Epilepsia"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00880.x"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1979.tb01612.x"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1159\/000137524"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978234371"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03258440"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.5.722"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200102000-00009"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(01)80042-4"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199801)13:1<29::AID-GPS726>3.0.CO;2-Z"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379804300108"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199700540-00010"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401239709147789"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0804"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.7.3.314"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199522330-00007"},{"key":"e_1_2_1_118_2","first-page":"430","article-title":"Divalproex sodium in the treatment of aggressive behaviour and dysphoria in patients with organic brain syndromes","volume":"56","author":"Horne M.","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1994.tb06571.x"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879300600404"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1007"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.54"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199610)11:10<901::AID-GPS409>3.0.CO;2-7"},{"key":"e_1_2_1_124_2","first-page":"354","article-title":"Effect of carbamazepine on agitation in Alzheimer's disease in patients refractory to neuroleptics","volume":"56","author":"Lemke M.R.","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1994.tb06982.x"},{"key":"e_1_2_1_126_2","first-page":"A75","article-title":"Comparison of carbamazepine and trazodone in the control of aggression\/agitation in demented, institutionalized patients: a randomized double blind parallel study [abstr]","volume":"39","author":"Mervis J.R.","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"e_1_2_1_127_2","first-page":"115","article-title":"Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics","volume":"51","author":"Gleason R.","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.6.805"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198878800100105"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198878800100208"},{"key":"e_1_2_1_131_2","first-page":"505","article-title":"Carbamazepine in senile dementia and overactivity\u2014a placebo controlled double blind trial","volume":"10","author":"Chambers C.A.","year":"1982","journal-title":"IRCS J Med Sci"},{"key":"e_1_2_1_132_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200002000-00015"},{"key":"e_1_2_1_133_2","first-page":"422","article-title":"Gabapentin in geriatric psychiatry patients","volume":"43","author":"Sheldon L.J.","year":"1998","journal-title":"Can J Psychiatry"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199813020-00011"},{"key":"e_1_2_1_135_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004714-199702000-00015","article-title":"Gabapentin for behavioral agitation in Alzheimer's disease","volume":"17","author":"Regan W.M.","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199801000-00013"},{"key":"e_1_2_1_137_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199801000-00012"},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n1010"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0207"},{"issue":"13","key":"e_1_2_1_140_2","first-page":"3","article-title":"Epidemiology, etiology, and treatment of geriatric mania","volume":"61","author":"McDonald W.M.","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_141_2","first-page":"273","volume-title":"Geriatric psychopharmacology","author":"Jefferson J.W.","year":"1997"},{"key":"e_1_2_1_142_2","first-page":"285","volume-title":"Geriatric psychopharmacology","author":"Bowden C.L.","year":"1997"},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0306"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<494::AID-GPS964>3.0.CO;2-9"},{"key":"e_1_2_1_145_2","first-page":"215","article-title":"Safety and efficacy of divalproex sodium in elderly bipolar patients [letter]","volume":"55","author":"Risinger R.C.","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00157-2"},{"key":"e_1_2_1_147_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879500800407"},{"key":"e_1_2_1_148_2","first-page":"479","article-title":"Valproate use in the older manic patient","volume":"51","author":"McFarland B.H.","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_149_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199808000-00008"},{"key":"e_1_2_1_150_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.1023"},{"key":"e_1_2_1_151_2","first-page":"238","article-title":"The use of valproate in an elderly population with affective symptoms","volume":"57","author":"Kando J.C.","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_152_2","first-page":"472","article-title":"Carbamazepine for treatment\u2010resistant melancholia","volume":"52","author":"Cullen M.","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_153_2","doi-asserted-by":"publisher","DOI":"10.1159\/000022127"},{"key":"e_1_2_1_154_2","first-page":"717","volume-title":"Neurodegenerative diseases","author":"Koller W.C.","year":"1994"},{"key":"e_1_2_1_155_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.12.1587"},{"key":"e_1_2_1_156_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.4.475"},{"key":"e_1_2_1_157_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130315"},{"key":"e_1_2_1_158_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199808000-00007"},{"key":"e_1_2_1_159_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01212087"},{"key":"e_1_2_1_160_2","first-page":"869","article-title":"Tegretol in the treatment of diabetic neuropathy","volume":"48","author":"Wilton T.D.","year":"1974","journal-title":"S Afr Med J"},{"key":"e_1_2_1_161_2","first-page":"403","article-title":"Double\u2010blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy","volume":"26","author":"Chadda V.S.","year":"1978","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_1_162_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1968.00480020015001"},{"key":"e_1_2_1_163_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1976.tb03996.x"},{"key":"e_1_2_1_164_2","first-page":"155","volume-title":"Adverse effects of antiepileptic drugs","author":"Schmidt D.","year":"1982"},{"key":"e_1_2_1_165_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199309030-00003"},{"key":"e_1_2_1_166_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.29.3.265"},{"key":"e_1_2_1_167_2","first-page":"37","volume-title":"Pain management for the practicing physician","author":"Irving G.A.","year":"1997"},{"key":"e_1_2_1_168_2","first-page":"187","volume-title":"Oxford textbook of palliative medicine","author":"Portenoy R.K.","year":"1993"},{"key":"e_1_2_1_169_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03853.x"},{"key":"e_1_2_1_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0690(18)30214-3"},{"key":"e_1_2_1_171_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/082585979401000409","article-title":"Neuropathic pain","volume":"10","author":"Billings J.A.","year":"1994","journal-title":"J Palliat Care"},{"key":"e_1_2_1_172_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1041082"},{"key":"e_1_2_1_173_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977222196"},{"key":"e_1_2_1_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)91959-0"},{"key":"e_1_2_1_175_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.37"},{"key":"e_1_2_1_176_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1831"},{"key":"e_1_2_1_177_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205073261904"},{"key":"e_1_2_1_178_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1837"},{"key":"e_1_2_1_179_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.9.1427"},{"issue":"4","key":"e_1_2_1_180_2","first-page":"104","article-title":"Studies on the concomitant use of carbamazepine and clomipramine for the relief of post\u2010herpetic neuralgia","volume":"53","author":"Gerson G.R.","year":"1997","journal-title":"Postgrad Med J"},{"key":"e_1_2_1_181_2","first-page":"399","article-title":"The management of postherpetic pain using sodium valproate and amitriptyline","volume":"72","author":"Raftery A.","year":"1979","journal-title":"J Irish Med Assoc"},{"key":"e_1_2_1_182_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1995.tb00622.x"},{"key":"e_1_2_1_183_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1963.00460090091009"},{"key":"e_1_2_1_184_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.57.663.16"},{"key":"e_1_2_1_185_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.12_Suppl_9.S17"},{"key":"e_1_2_1_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(89)90108-5"},{"key":"e_1_2_1_187_2","doi-asserted-by":"publisher","DOI":"10.1177\/026921630001400216"},{"key":"e_1_2_1_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(96)03168-5"},{"key":"e_1_2_1_189_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7012.1047"},{"key":"e_1_2_1_190_2","first-page":"659","article-title":"Pharmacy\u2010based adverse drug reaction monitoring program","volume":"5","author":"Cooper S.L.","year":"1990","journal-title":"Consult Pharm"},{"key":"e_1_2_1_191_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03842.x"},{"key":"e_1_2_1_192_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)30380-3"},{"key":"e_1_2_1_193_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430100086010"},{"key":"e_1_2_1_194_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1979.tb01715.x"},{"key":"e_1_2_1_195_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198712010-00004"},{"key":"e_1_2_1_196_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02395213"},{"key":"e_1_2_1_197_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1975.tb00475.x"},{"key":"e_1_2_1_198_2","first-page":"5","volume-title":"Applied pharmacokinetics: principles of therapeutic drug monitoring","author":"MacKichan J.J.","year":"1992"},{"issue":"5","key":"e_1_2_1_199_2","first-page":"S53","article-title":"Pharmacokinetic pitfalls of present antiepileptic medications","volume":"32","author":"Cloyd J.","year":"1991","journal-title":"Epilepsia"},{"key":"e_1_2_1_200_2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-3565(25)24109-X","article-title":"Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S\u2010mephenytoin 4\u2010hydroxylation","volume":"245","author":"Knodell R.G.","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_201_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280051"},{"key":"e_1_2_1_202_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb03307.x"},{"key":"e_1_2_1_203_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3565(24)36457-2","article-title":"Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers","volume":"80","author":"Loi C.M.","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_204_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.55"},{"key":"e_1_2_1_205_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107938"},{"key":"e_1_2_1_206_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(95)00047-X"},{"key":"e_1_2_1_207_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02448.x"},{"key":"e_1_2_1_208_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)80073-3"},{"key":"e_1_2_1_209_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1987.tb05778.x"},{"key":"e_1_2_1_210_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550100086018"},{"issue":"7","key":"e_1_2_1_211_2","first-page":"105","article-title":"Adverse events (AEs) when topiramate is titrated to effect: results from an open\u2010label, in\u2010practice study with 800+ patients [abstr]","volume":"41","author":"Pellock J.M.","year":"2000","journal-title":"Epilepsia"},{"key":"e_1_2_1_212_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb05999.x"},{"key":"e_1_2_1_213_2","first-page":"77","article-title":"Epilepsy, anticonvulsant drugs and cognition","volume":"5","author":"Drane D.L.","year":"1996","journal-title":"Ballieres Clin Neurol"},{"key":"e_1_2_1_214_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009744"},{"key":"e_1_2_1_215_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050120"},{"key":"e_1_2_1_216_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503233321202"},{"key":"e_1_2_1_217_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb05199.x"},{"key":"e_1_2_1_218_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440270035003"},{"key":"e_1_2_1_219_2","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0301"},{"key":"e_1_2_1_220_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02441226"},{"key":"e_1_2_1_221_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1986.tb03515.x"},{"key":"e_1_2_1_222_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090507"},{"key":"e_1_2_1_223_2","first-page":"37","article-title":"Long\u2010term anticonvulsant therapy leads to low bone mineral density: evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast\u2010like cells","volume":"108","author":"Feldkamp J.","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"e_1_2_1_224_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-9-199305010-00001"},{"key":"e_1_2_1_225_2","first-page":"70","article-title":"Strategies to protect bone mass in the older patient with epilepsy","volume":"52","author":"Cohen A.","year":"1997","journal-title":"Geriatrics"},{"key":"e_1_2_1_226_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-6-1003"},{"key":"e_1_2_1_227_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1982.tb06853.x"},{"key":"e_1_2_1_228_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70304-7"},{"key":"e_1_2_1_229_2","first-page":"23","volume-title":"Antiepileptic drugs","author":"Perucca E.","year":"1989"},{"key":"e_1_2_1_230_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502023320506"},{"key":"e_1_2_1_231_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb04519.x"},{"key":"e_1_2_1_232_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb02575.x"},{"key":"e_1_2_1_233_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785"},{"key":"e_1_2_1_234_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199411060-00004"},{"key":"e_1_2_1_235_2","volume-title":"Depakote ER (divalproex sodium, extended\u2010release) package insert","author":"Abbott Laboratories.","year":"2000"},{"key":"e_1_2_1_236_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17332"},{"key":"e_1_2_1_237_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390040096019"},{"key":"e_1_2_1_238_2","volume-title":"Extended phenytoin sodium package insert","author":"Mylan Laboratories.","year":"2000"},{"key":"e_1_2_1_239_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70132-3"},{"key":"e_1_2_1_240_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600641030"},{"key":"e_1_2_1_241_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703100301"},{"key":"e_1_2_1_242_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975184425"},{"key":"e_1_2_1_243_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198106050-00005"},{"key":"e_1_2_1_244_2","first-page":"1193","article-title":"Phenytoin and serum phenytoin variability among patients in a long\u2010term care facility","volume":"7","author":"Elliott D.P.","year":"1992","journal-title":"Consult Pharm"},{"key":"e_1_2_1_245_2","doi-asserted-by":"publisher","DOI":"10.1159\/000261155"},{"key":"e_1_2_1_246_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.5.570"},{"key":"e_1_2_1_247_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03128.x"},{"key":"e_1_2_1_248_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198210283071812"},{"key":"e_1_2_1_249_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198917040-00003"},{"key":"e_1_2_1_250_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb02965.x"},{"key":"e_1_2_1_251_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02930.x"},{"key":"e_1_2_1_252_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.7.961"},{"key":"e_1_2_1_253_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600650344"},{"key":"e_1_2_1_254_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198712000-00007"},{"key":"e_1_2_1_255_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(80)90017-4"},{"key":"e_1_2_1_256_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198612000-00005"},{"key":"e_1_2_1_257_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-197901000-00011"},{"key":"e_1_2_1_258_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02401.x"},{"key":"e_1_2_1_259_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.116"},{"key":"e_1_2_1_260_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb02151.x"},{"key":"e_1_2_1_261_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700107"},{"key":"e_1_2_1_262_2","volume-title":"Idiosyncratic reactions to valproate. Clinical risk patterns and mechanisms of toxicity","author":"Levy R.H.","year":"1992"},{"key":"e_1_2_1_263_2","first-page":"117","article-title":"Valproate\u2010associated pancreatitis","volume":"34","author":"Asconape J.J.","year":"1992","journal-title":"Epilepsia"},{"key":"e_1_2_1_264_2","volume-title":"Depacon (valproate sodium intravenous) package insert","author":"Abbott Laboratories.","year":"2000"},{"key":"e_1_2_1_265_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1977.tb00783.x"},{"key":"e_1_2_1_266_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03820.x"},{"key":"e_1_2_1_267_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00642.x"},{"key":"e_1_2_1_268_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018951214146"},{"key":"e_1_2_1_269_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06001.x"},{"key":"e_1_2_1_270_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.118"},{"key":"e_1_2_1_271_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00743.x"},{"key":"e_1_2_1_272_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199708000-00006"},{"key":"e_1_2_1_273_2","first-page":"121","article-title":"Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers","volume":"1","author":"Posner J.","year":"1991","journal-title":"J Pharm Med"},{"key":"e_1_2_1_274_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346010-00009"},{"key":"e_1_2_1_275_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1997.tb00028.x"},{"key":"e_1_2_1_276_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06002.x"},{"key":"e_1_2_1_277_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200118080-00006"},{"key":"e_1_2_1_278_2","volume-title":"Trileptal (levetiracetam). Data on file","author":"UCB Pharma.","year":"2000"},{"key":"e_1_2_1_279_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(99)00052-2"},{"key":"e_1_2_1_280_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00194967"},{"key":"e_1_2_1_281_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.158"},{"key":"e_1_2_1_282_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1993.tb04106.x"},{"key":"e_1_2_1_283_2","first-page":"33","article-title":"Two new drugs for epilepsy","volume":"42","year":"2000","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_2_1_284_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00918.x"},{"key":"e_1_2_1_285_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(89)90070-3"},{"key":"e_1_2_1_286_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.4.732"},{"key":"e_1_2_1_287_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(88)90018-6"},{"key":"e_1_2_1_288_2","doi-asserted-by":"publisher","DOI":"10.1177\/096032718900800501"},{"key":"e_1_2_1_289_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb01772.x"},{"key":"e_1_2_1_290_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04282.x"},{"key":"e_1_2_1_291_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01182.x"},{"key":"e_1_2_1_292_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550170069016"},{"key":"e_1_2_1_293_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01734.x"},{"key":"e_1_2_1_294_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01272.x"},{"key":"e_1_2_1_295_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06009.x"},{"issue":"2","key":"e_1_2_1_296_2","first-page":"S18","article-title":"Safety of topiramate: adverse events and relationships to dosing","volume":"36","author":"Shorvon S.D.","year":"1995","journal-title":"Epilepsia"},{"key":"e_1_2_1_297_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)80037-X"},{"issue":"3","key":"e_1_2_1_298_2","first-page":"S153","article-title":"Investigation of the mechanistic basis of topiramate\u2010associated nephrolithiasis of urinary and serum constituents [abstr]","volume":"36","author":"Wasserstein A.G.","year":"1995","journal-title":"Epilepsia"},{"key":"e_1_2_1_299_2","first-page":"190","article-title":"Pharmacokinetics of zonisamide in young and elderly subjects [abstr]","volume":"39","author":"Wallace J.","year":"1998","journal-title":"Epilepsia"},{"key":"e_1_2_1_300_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06004.x"},{"key":"e_1_2_1_301_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ajhp\/52.1.88","article-title":"New opportunities for the treatment of epilepsy","volume":"52","author":"Garnett W.R.","year":"1995","journal-title":"Am J Health-Syst Pharm"},{"key":"e_1_2_1_302_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(94)90045-0"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.22.5.329.33192","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.22.5.329.33192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:06:03Z","timestamp":1761059163000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.22.5.329.33192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":301,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1592\/phco.22.5.329.33192"],"URL":"https:\/\/doi.org\/10.1592\/phco.22.5.329.33192","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}